Skip to main content
logo
Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.120
-0.040 (-3.45%)
At close: Sep 1, 2026, 4:00 PM EDT
1.100
-0.020 (-1.79%)
After-hours: Sep 1, 2026, 5:31 PM EDT

Cocrystal Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.33-----
Revenue Growth
------
Cost of Revenue
6.095.0612.5415.1712.398.79
Gross Profit
-5.76-5.06-12.54-15.17-12.39-8.79
Selling, General & Admin
4.353.965.345.995.755.43
Operating Expenses
4.353.965.345.995.755.43
Operating Income
-10.11-9.02-17.88-21.16-18.14-14.22
Interest Expense
-----0-0
Interest & Investment Income
0.10.130.540.64--
Currency Exchange Gain (Loss)
0.070.05-0.16-0.07-0.02-0.01
Other Non Operating Income (Expenses)
----0.010.05
EBT Excluding Unusual Items
-9.94-8.83-17.5-20.58-18.15-14.19
Impairment of Goodwill
-----19.09-
Legal Settlements
---2.6-1.6-
Pretax Income
-9.94-8.83-17.5-17.98-38.84-14.19
Net Income
-9.94-8.83-17.5-17.98-38.84-14.19
Net Income to Common
-9.94-8.83-17.5-17.98-38.84-14.19
Net Income Growth
------
Shares Outstanding (Basic)
1311101087
Shares Outstanding (Diluted)
1311101087
Shares Change
28.73%10.97%5.42%18.52%10.58%60.04%
EPS (Basic)
-0.76-0.78-1.72-1.86-4.77-1.93
EPS (Diluted)
-0.76-0.78-1.72-1.86-4.77-1.93
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-7.97-8.2-16.49-14.78-21.51-12.77
Free Cash Flow Per Share
-0.61-0.73-1.62-1.53-2.64-1.73
Operating Margin
-3063.64%-----
Profit Margin
-3011.51%-----
Free Cash Flow Margin
-2413.94%-----
EBITDA
-10.06-8.95-17.75-20.97-17.95-14.03
D&A For EBITDA
0.050.070.130.190.190.19
EBIT
-10.11-9.02-17.88-21.16-18.14-14.22
SEC Filings: 10-K · 10-Q